Sr One Capital Management, LP Crispr Therapeutics Ag Transaction History
Sr One Capital Management, LP
- $435 Million
- Q3 2025
A detailed history of Sr One Capital Management, LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Sr One Capital Management, LP holds 2,038,763 shares of CRSP stock, worth $113 Million. This represents 30.4% of its overall portfolio holdings.
Number of Shares
2,038,763
Previous 1,048,951
94.36%
Holding current value
$113 Million
Previous $51 Million
158.98%
% of portfolio
30.4%
Previous 18.29%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
548Shares Held
67.7MCall Options Held
3.56MPut Options Held
3.11M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.79MShares$541 Million4.45% of portfolio
-
Capital International Investors Los Angeles, CA5.65MShares$313 Million0.06% of portfolio
-
Orbis Allan Gray LTD Hamilton, D04.98MShares$276 Million1.8% of portfolio
-
State Street Corp Boston, MA4.01MShares$222 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.28MShares$182 Million0.13% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.32B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....